Dr. Klein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Rockledge Dr
Suite 410
Bethesda, MD 20817Phone+1 301-530-9744Fax+1 301-530-0046
Education & Training
- Beth Israel Deaconess Medical Center/Children's Hospital/Harvard Medical SchoolFellowship, Clinical Neurophysiology, 1998
- University of Cambridge School of MedicineClass of 1980
Certifications & Licensure
- MD State Medical License 1998 - 2026
- VA State Medical License 1989 - 2026
- NJ State Medical License 2022 - 2025
- DC State Medical License 1999 - 2013
- MA State Medical License 1994 - 2000
- GA State Medical License 1990 - 1997
- TN State Medical License 1990 - 1996
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Epilepsy
Awards, Honors, & Recognition
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Top Doctors:Baltimore Area Castle Connolly, 2012
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy Start of enrollment: 2010 Jun 01
- Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study Start of enrollment: 2013 Jan 01
- Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsSeizure clusters, rescue treatments, seizure action plans: Unmet needs and emerging formulations.Barry E. Gidal, Pavel Klein, Lawrence J. Hirsch
Epilepsy & Behavior. 2020-09-06 - 11 citationsFailure to use new breakthrough treatments for epilepsy.Pavel Klein, Gregory L Krauss, Bernhard J Steinhoff, Orrin Devinsky, Michael R Sperling
Epilepsia. 2023-06-01 - 95 citationsCenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.Michael R. Sperling, Pavel Klein, Sami Aboumatar, Michael A. Gelfand, Jonathan J. Halford
Epilepsia. 2020-06-01
Press Mentions
- Expert Consensus Opinions Published in Neurology and Therapy Discuss Adjustment of Anti-Seizure Medication Dosing for Optimal CareSeptember 12th, 2022
- 'No Evidence' Newer Antiseizure Medications Increase Risk for SuicidalityAugust 9th, 2021
- Novela Neurotech Joins the 2021 UCSF Rosenman InnovatorsJune 17th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: